Navigation Links
Candidate vaccine to reduce hepatitis C viral load.

Hepatitis C virus is the leading cause of death and liver transplant in the western world. This disease is also very common that it is incidence is five times more when compared to HIV/ AIDS. // Hence researchers at the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) have developed a vaccine candidate to treat hepatitis C infection.

This vaccine technique is very effective in the treatment of Hepatitis C (HCV) infection. It reduced the load of the carrier virus in the body of the mice tremendously in the order of 100000 times when compared to the control. The Canadian Institutes of Health Research (CIHR) and the Canadian Network for Vaccines and Immunotherapeutics (CANVAC) funded the research.

The researchers mainly made use of the dendritic cells to fight against the Hepatitis C virus. Dendritic cells play an important role in activation of the immune system. The vaccine significantly reduced the amount of viral protein in the body. This help us to later develop treatments which will pave way to help the patients suffering from liver disease caused by the virus.

People (20%) who have the disease remove the virus without any major problem. When the disease becomes chronic then the immune system finds it difficult to remove the viral load from the body. But studies reveal that in patients suffering from chronic hepatitis there is alteration in the function of the dendritic cells.

Hence these vaccines were created which could signal the dendritic cell and help in the proper activation of the immune system. Then the patient is in a position to control from the body.

The designing of a vaccine is very time consuming and troublesome because the virus always keeps mutating. A patient suffering from the disease may harbor with many different types of strains. Hence the VIDO came up with a vaccine that has a broad range of action and is effective against all strains.


'"/>




Page: 1

Related medicine news :

1. New Test Identifies Candidates For Cardiac Defibrillator
2. HIV-Positive Woman To Be Congress Candidate In Assam
3. Reservation For SC/ST Candidates Under 50% All India Quota
4. New hope for cancer victims – will vaccine cure the deadly bug
5. New vaccine helps allergy and asthma patients
6. Man against HIV – new vaccine ready for human trials
7. New vaccine helps allergy and asthma patients
8. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
9. HIV did not arise from polio vaccine
10. Double impact vaccine
11. High Demand for a child vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to announce the ... July 17, 2017, Ms. Vu will join West Dermatology’s large network of medical and ... skin cancer , and more. She graduated from the University of Florida College ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... (ACL) offer patients improved quality of life five years after injury, according to ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five years ...
(Date:7/20/2017)... Viejo, CA (PRWEB) , ... July 20, 2017 , ... ... when placed between two clips in the FCPX timeline. This effect isolates horizontal and ... transition in this package contains either a rotating or flipping animation and can be ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) ... progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a ... relapse. With such a challenging diagnosis that requires immediate action, patients and ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... law firm headquartered in Houston, is pleased to announce their expansion to the ... affordable housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John ...
Breaking Medicine News(10 mins):
(Date:6/30/2017)... , June 30, 2017 In vitro ... the start of May, at least ten diagnostic companies ... private investments, public offerings and a loan facility.  The ... to almost $80 million.  Kalorama Information provides a monthly ... its Diagnostics Knowledge Center. ...
(Date:6/30/2017)... HIGH POINT, N.C. , June 29, 2017  Axium Pharmaceuticals ... innovations for developing improved novel formulations and alternative dosage forms ... ... transmucosal delivery is based on our waterless self-nano emulsifying formula, ... after contact with saliva. We believe the spray will provide ...
(Date:6/27/2017)... , Jun 27, 2017   NuEyes (NuEyes Technologies ... funding to fuel its growth in helping the legally blind ... (Osterhout Design Group), the leading developer of augmented, virtual and ... sits. The undisclosed funding amount was provided by ... Arab Angel, with offices in Abu Dhabi ...
Breaking Medicine Technology: